Windtree Therapeutics Inc (WINT)
3.90
+0.28
(+7.73%)
USD |
NASDAQ |
May 24, 16:00
3.93
+0.03
(+0.77%)
After-Hours: 20:00
Windtree Therapeutics Accounts Payable (Quarterly): 1.689M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 1.689M |
December 31, 2023 | 0.809M |
September 30, 2023 | 0.944M |
June 30, 2023 | 0.964M |
March 31, 2023 | 0.753M |
December 31, 2022 | 0.249M |
September 30, 2022 | 0.41M |
June 30, 2022 | 1.072M |
March 31, 2022 | 0.724M |
December 31, 2021 | 0.693M |
September 30, 2021 | 0.582M |
June 30, 2021 | 0.288M |
March 31, 2021 | 0.939M |
December 31, 2020 | 1.161M |
September 30, 2020 | 0.726M |
June 30, 2020 | 1.223M |
March 31, 2020 | 1.401M |
December 31, 2019 | 1.708M |
September 30, 2019 | 0.607M |
June 30, 2019 | 0.724M |
March 31, 2019 | 1.417M |
December 31, 2018 | 3.42M |
September 30, 2018 | 4.519M |
June 30, 2018 | 4.258M |
March 31, 2018 | 4.683M |
Date | Value |
---|---|
December 31, 2017 | 2.324M |
September 30, 2017 | 3.77M |
June 30, 2017 | 2.846M |
March 31, 2017 | 2.312M |
December 31, 2016 | 1.813M |
September 30, 2016 | 5.237M |
June 30, 2016 | 7.713M |
March 31, 2016 | 5.512M |
December 31, 2015 | 0.369M |
September 30, 2015 | 2.457M |
June 30, 2015 | 2.314M |
March 31, 2015 | 0.702M |
December 31, 2014 | 0.35M |
September 30, 2014 | 1.403M |
June 30, 2014 | 1.507M |
March 31, 2014 | 2.578M |
December 31, 2013 | 1.433M |
September 30, 2013 | 1.489M |
June 30, 2013 | 1.919M |
March 31, 2013 | 1.825M |
December 31, 2012 | 1.166M |
September 30, 2012 | 0.208M |
June 30, 2012 | 1.335M |
March 31, 2012 | 1.339M |
December 31, 2011 | 1.111M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.249M
Minimum
Dec 2022
1.708M
Maximum
Dec 2019
0.8833M
Average
0.781M
Median
Accounts Payable (Quarterly) Benchmarks
Lexicon Pharmaceuticals Inc | 8.067M |
AIM ImmunoTech Inc | 6.567M |
Perspective Therapeutics Inc | 6.027M |
Protalix BioTherapeutics Inc | 3.146M |
Armata Pharmaceuticals Inc | 2.057M |